The information on this page is for informational purposes only and does not constitute medical advice. Consult your genetic counselor or specialist physician for treatment decisions.

Genetics of Mendelian Forms of Young Onset Alzheimer Disease

Plain-language summary

This study investigates the genetics of hereditary (Mendelian) forms of young-onset Alzheimer's disease (beginning before age 65). It included families with at least two Alzheimer's cases with onset under age 65. It is an observational (non-phase) study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase
Not Applicable
Status
Completed
Sponsor
University Hospital, Rouen
Intervention
Genetic-Tailored AntiThrombotic Strategy
Start date
11/15/2009
Estimated completion
12/15/2018
Countries
France

Related genes

Locations

  • Rouen, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* \> in one family 2 cases of Alzheimer disease with age of onset under 65

Exclusion Criteria:

* other cases of young onset dementia
This is not medical advice. Consult your specialist.
View the official record on ClinicalTrials.gov →